Clozapine, marketed in Australia since 1993, is an effective antipsychotic for the management of treatment-resistant schizophrenia.
氯氮平，自从1993年在澳大利亚上市以来，一直作为一种有效的抗。
These discoveries may have clinical implications for the approximately 33 percent of schizophrenia patients whose auditory hallucinations are resistant to treatment, Cachia told Psychiatric News.
卡夏告诉《精神病新闻》，这些发现对临床产生一定的意义，介于33%的具有幻听的精神分裂症患者对过去治疗阻抗。
In this article, the author reviewed biological factors, drug treatment and non - drug treatment of the treatment resistant schizophrenia, and provided theoretical guidance for clinical treatment.
综述了难治性精神分裂症的生物学因素、药物治疗和非药物治疗方面的进展，为临床治疗提供理论指导。
In this article, the author reviewed biological factors, drug treatment and non - drug treatment of the treatment resistant schizophrenia, and provided theoretical guidance for clinical treatment.
综述了难治性精神分裂症的生物学因素、药物治疗和非药物治疗方面的进展，为临床治疗提供理论指导。
应用推荐